Montgomery County next-generation cell therapy manufacturing facility
Johnson & Johnson, Lower Gwynedd Township, Montgomery County, Pennsylvania
Montgomery County next-generation cell therapy manufacturing facility in Lower Gwynedd Township, Pennsylvania is Johnson & Johnson’s plant for cell therapies (cancer, immune-mediated and neurological diseases). Status: announced as of February 18, 2026. Johnson & Johnson announced $1.0 billion and 500 jobs. Primary source: jnj.com, checked November 12, 2026.
- Status
- Announced
- Announced investment
- $1.0 billion
- Announced jobs
- 500
- Industry
- Pharmaceuticals
- Sheet
- PA-15
- Revised
- November 12, 2026
Status timeline
- Announcedjnj.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Johnson & Johnson |
|---|---|
| Plant | Montgomery County next-generation cell therapy manufacturing facility |
| Location | Lower Gwynedd Township, Montgomery County, Pennsylvania |
| Industry | Pharmaceuticals |
| Product | Cell therapies (cancer, immune-mediated and neurological diseases) |
| Announced investment | $1.0 billionMore than $1 billion; part of J&J's $55 billion U.S. investment through early 2029 |
| Announced jobs | 500 |
| Last checked | November 12, 2026 |
Sources
- J&J: more than $1 billion cell therapy manufacturing facility in Pennsylvania (company release, jnj.com, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.